Literature DB >> 10750965

A qualitative analysis of brain SPECT for prognostication of gross motor development in children with cerebral palsy.

S Y Yim1, I Y Lee, C H Park, O H Kim.   

Abstract

PURPOSE: In this report, the authors assessed the clinical significance of decreased regional cerebral blood flow (rCBF) in the thalamus or cerebellar hemispheres in relation to gross motor performance in the children with cerebral palsy.
MATERIALS AND METHODS: Thirty-six children with bilateral spastic cerebral palsy (BSCP) underwent brain SPECT. Visual analysis was used for the brain SPECT interpretation. The rCBF in the thalamus or cerebellum was graded as normal, mildly decreased, or severely decreased. A marked decrease or near absence of rCBF in the thalamus or cerebellum was considered as severely decreased.
RESULTS: All 36 children with BSCP had hypoperfusion in the thalamus or cerebellar hemispheres. Eight of 20 children (40%) with mildly decreased rCBF on brain SPECT had mild developmental delays. On the other hand, only 1 of 16 children (6.3%) with severe hypoperfusion in the thalamus or cerebellum had a mild developmental delay, and the remaining 15 of 16 children (93.8%) had severe developmental delays. There was good correlation between the degree of developmental delay and the severity of hypoperfusion in the thalamus or cerebellum (P = 0.023).
CONCLUSION: The measurement of rCBF by Tc-99m ethyl cysteinate dimer brain SPECT appears to be valuable in prognostication of gross motor development in children with BSCP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750965     DOI: 10.1097/00003072-200004000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  1 in total

1.  99mTc-ECD brain perfusion SPECT imaging for the assessment of brain perfusion in cerebral palsy (CP) patients with evaluation of the effect of hyperbaric oxygen therapy.

Authors:  Mina Taghizadeh Asl; Farzaneh Yousefi; Reza Nemati; Majid Assadi
Journal:  Int J Clin Exp Med       Date:  2015-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.